Arlington Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37K | Sell |
1,527
-2,850
| -65% | -$69.1K | 0.01% | 388 |
|
|
2025
Q1 | $111K | Sell |
4,377
-2,631
| -38% | -$66.7K | 0.02% | 248 |
|
|
2024
Q4 | $186K | Sell |
7,008
-3,805
| -35% | -$101K | 0.04% | 188 |
|
|
2024
Q3 | $313K | Sell |
10,813
-388
| -3% | -$11.2K | 0.07% | 126 |
|
|
2024
Q2 | $313K | Buy |
11,201
+6,801
| +155% | +$190K | 0.07% | 119 |
|
|
2024
Q1 | $122K | Sell |
4,400
-131
| -3% | -$3.64K | 0.03% | 195 |
|
|
2023
Q4 | $130K | Buy |
4,531
+2,771
| +157% | +$79.8K | 0.04% | 185 |
|
|
2023
Q3 | $58.4K | Buy |
+1,760
| New | +$58.4K | 0.02% | 132 |
|